Sangeeta Goswami

13PUBLICATIONS
106CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 18, 2026
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

|Mar 10, 2026
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma.

JongHoon Ha, Yifan Wang, Yifan Ma

|Jan 07, 2026
Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer.

Pratishtha Singh, Ranit D'Rozario, Bidisha Chakraborty

|Sep 10, 2025
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Jielin Liu, Shelley Herbrich, Sreyashi Basu

|Apr 28, 2025
Investigative needle core biopsies support multimodal deep-data generation in glioblastoma.

Kenny K H Yu, Sreyashi Basu, Gerard Baquer

|Mar 25, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome.

Candice C Poon, Shelley M Herbrich, Yulong Chen

Pageof 3

Frequent Collaborators

11 joint publications

Padmanee Sharma

9 joint publications

Sreyashi Basu

7 joint publications

Sonali Jindal

4 joint publications

Frederick F Lang